{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:04:05Z","timestamp":1792073045647,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research & Developmental Program of China","award":["2022YFC2702600"],"award-info":[{"award-number":["2022YFC2702600"]}]},{"name":"National Key Research & Developmental Program of China","award":["2022YFC2702600"],"award-info":[{"award-number":["2022YFC2702600"]}]},{"name":"National Clinical Key Specialty Construction Program, P. R. China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04245-4","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:21:23Z","timestamp":1746850883000},"page":"614-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["GLP-1 receptor agonists show no detrimental effect on sperm quality in mouse models and cell lines"],"prefix":"10.1007","volume":"89","author":[{"given":"Deshan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"4245_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10020-023-00771-x","volume":"30","author":"R Huang","year":"2024","unstructured":"R. Huang, J. Chen, B. Guo, C. Jiang, W. Sun, Diabetes-induced male infertility: potential mechanisms and treatment options. Mol Med 30, 11 (2024). https:\/\/doi.org\/10.1186\/s10020-023-00771-x.","journal-title":"Mol Med"},{"key":"4245_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2024.02.006","volume":"214","author":"Y Cao","year":"2024","unstructured":"Y. Cao, Z. Jin, Y. Xi, J. Cheng, Z. Fang, Q. Zhao et al., Roles of ferroptosis in type 1 diabetes induced spermatogenic dysfunction. Free Radic. Biol. Med 214, 193\u2013205 (2024). https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.02.006.","journal-title":"Free Radic. Biol. Med"},{"key":"4245_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41572-023-00459-w","volume":"9","author":"ML Eisenberg","year":"2023","unstructured":"M.L. Eisenberg, S.C. Esteves, D.J. Lamb, J.M. Hotaling, A. Giwercman, K. Hwang et al., Male infertility. Nat Rev. Dis. Prim. 9, 49 (2023). https:\/\/doi.org\/10.1038\/s41572-023-00459-w.","journal-title":"Nat Rev. Dis. Prim."},{"key":"4245_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s11154-022-09726-9","volume":"23","author":"DF Carrageta","year":"2022","unstructured":"D.F. Carrageta, B. Guerra-Carvalho, M.A. Spadella, M. Yeste, P.F. Oliveira, M.G. Alves, Animal models of male reproductive ageing to study testosterone production and spermatogenesis. Rev Endocr. Metab. Disord. 23, 1341\u20131360 (2022). https:\/\/doi.org\/10.1007\/s11154-022-09726-9.","journal-title":"Rev Endocr. Metab. Disord."},{"key":"4245_CR5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/s0140-6736(87)91194-9","volume":"2","author":"B Kreymann","year":"1987","unstructured":"B. Kreymann, G. Williams, M.A. Ghatei, S.R. Bloom, Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300\u20131304 (1987). https:\/\/doi.org\/10.1016\/s0140-6736(87)91194-9.","journal-title":"Lancet"},{"key":"4245_CR6","doi-asserted-by":"publisher","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","volume":"384","author":"H Yao","year":"2024","unstructured":"H. Yao, A. Zhang, D. Li, Y. Wu, C.Z. Wang, J.Y. Wan et al., Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. Bmj 384, e076410 (2024). https:\/\/doi.org\/10.1136\/bmj-2023-076410.","journal-title":"Bmj"},{"key":"4245_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/ijms25031909","volume":"25","author":"P Pavli","year":"2024","unstructured":"P. Pavli, O. Triantafyllidou, E. Kapantais, N.F. Vlahos, G. Valsamakis, Infertility improvement after medical weight loss in women and men: a review of the literature. Int J. Mol. Sci. 25, 1909 (2024). https:\/\/doi.org\/10.3390\/ijms25031909.","journal-title":"Int J. Mol. Sci."},{"key":"4245_CR8","doi-asserted-by":"publisher","unstructured":"C. Able, B. Liao, G. Saffati, A. Maremanda, J. Applewhite, A.A. Nasrallah et al. Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study. Int J Impot Res. Published online. (2024). https:\/\/doi.org\/10.1038\/s41443-024-00895-6","DOI":"10.1038\/s41443-024-00895-6"},{"key":"4245_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104567","volume":"25","author":"X Cui","year":"2022","unstructured":"X. Cui, J. Feng, T. Wei, L. Gu, D. Wang, S. Lang et al., Pro-\u03b1-cell-derived \u03b2-cells contribute to \u03b2-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice. iScience 25, 104567 (2022). https:\/\/doi.org\/10.1016\/j.isci.2022.104567.","journal-title":"iScience"},{"key":"4245_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn3773","volume":"8","author":"MM Holter","year":"2022","unstructured":"M.M. Holter, D.J. Phuong, I. Lee, M. Saikia, L. Weikert, S. Fountain et al., 14-3-3-zeta mediates GLP-1 receptor agonist action to alter \u03b1 cell proglucagon processing. Sci Adv. 8, eabn3773 (2022). https:\/\/doi.org\/10.1126\/sciadv.abn3773.","journal-title":"Sci Adv."},{"key":"4245_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2019.02.037","volume":"41","author":"J Liu","year":"2019","unstructured":"J. Liu, K. Yang, J. Yang, W. Xiao, Y. Le, F. Yu et al., Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. EBioMedicine 41, 73\u201384 (2019). https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.037.","journal-title":"EBioMedicine"},{"key":"4245_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"M.H. Noyan-Ashraf, M.A. Momen, K. Ban, A.M. Sadi, Y.Q. Zhou, A.M. Riazi et al., GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58, 975\u2013983 (2009). https:\/\/doi.org\/10.2337\/db08-1193.","journal-title":"Diabetes"},{"key":"4245_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ki.2013.427","volume":"85","author":"H Fujita","year":"2014","unstructured":"H. Fujita, T. Morii, H. Fujishima, T. Sato, T. Shimizu, M. Hosoba et al., The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int 85, 579\u2013589 (2014). https:\/\/doi.org\/10.1038\/ki.2013.427.","journal-title":"Kidney Int"},{"key":"4245_CR14","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1096\/fj.14-269043","volume":"29","author":"OL Blanchard","year":"2015","unstructured":"O.L. Blanchard, J.M. Smoliga, Translating dosages from animal models to human clinical trials\u2013revisiting body surface area scaling. Faseb j. 29, 1629\u20131634 (2015). https:\/\/doi.org\/10.1096\/fj.14-269043.","journal-title":"Faseb j."},{"key":"4245_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40262-016-0413-4","volume":"55","author":"JK Mader","year":"2016","unstructured":"J.K. Mader, L. Jensen, S.H. Ingwersen, E. Christiansen, S. Heller, T.R. Pieber, Pharmacokinetic properties of liraglutide as adjunct to insulin in subjects with type 1 diabetes mellitus. Clin Pharmacokinet. 55, 1457\u20131463 (2016). https:\/\/doi.org\/10.1007\/s40262-016-0413-4.","journal-title":"Clin Pharmacokinet."},{"key":"4245_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2337\/db22-0784","volume":"72","author":"T Wei","year":"2023","unstructured":"T. Wei, X. Cui, Y. Jiang, K. Wang, D. Wang, F. Li et al., Glucagon acting at the GLP-1 receptor contributes to \u03b2-cell regeneration induced by glucagon receptor antagonism in diabetic mice. Diabetes 72, 599\u2013610 (2023).","journal-title":"Diabetes"},{"key":"4245_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/db23-0553","volume":"73","author":"Y Jiang","year":"2024","unstructured":"Y. Jiang, J. Yang, L. Xia, T. Wei, X. Cui, D. Wang et al., Gut microbiota-tryptophan metabolism-GLP-1 axis participates in \u03b2-cell regeneration induced by dapagliflozin. Diabetes 73, 926\u2013940 (2024). https:\/\/doi.org\/10.2337\/db23-0553.","journal-title":"Diabetes"},{"key":"4245_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01659-y","volume":"11","author":"Z Jin","year":"2023","unstructured":"Z. Jin, Y. Yang, Y. Cao, Q. Wen, Y. Xi, J. Cheng et al., The gut metabolite 3-hydroxyphenylacetic acid rejuvenates spermatogenic dysfunction in aged mice through GPX4-mediated ferroptosis. Microbiome 11, 212 (2023). https:\/\/doi.org\/10.1186\/s40168-023-01659-y.","journal-title":"Microbiome"},{"key":"4245_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/aja202242","volume":"25","author":"ZC Luo","year":"2023","unstructured":"Z.C. Luo, Z.R. Jin, Y.F. Jiang, T.J. Wei, Y.L. Cao, Z. Zhang et al., The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction. Asian J. Androl. 25, 331\u2013338 (2023). https:\/\/doi.org\/10.4103\/aja202242.","journal-title":"Asian J. Androl."},{"key":"4245_CR20","doi-asserted-by":"publisher","first-page":"e240274","DOI":"10.1530\/joe-24-0274","volume":"263","author":"ME Dasso","year":"2024","unstructured":"M.E. Dasso, C.L. Centola, M.N. Galardo, S.B. Meroni, M.F. Riera, Glucagon-like peptide-1 analog, liraglutide, regulates Sertoli cell energy metabolism. J Endocrinol. 263, e240274 (2024). https:\/\/doi.org\/10.1530\/joe-24-0274.","journal-title":"J Endocrinol."},{"key":"4245_CR21","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2147\/dddt.S470826","volume":"18","author":"XD Yang","year":"2024","unstructured":"X.D. Yang, Y.Y. Yang, Clinical pharmacokinetics of semaglutide: a systematic review. Drug Des. Devel Ther. 18, 2555\u20132570 (2024). https:\/\/doi.org\/10.2147\/dddt.S470826.","journal-title":"Drug Des. Devel Ther."},{"key":"4245_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/0091270009354996","volume":"50","author":"E Watson","year":"2010","unstructured":"E. Watson, D.M. Jonker, L.V. Jacobsen, S.H. Ingwersen, Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide. J Clin. Pharm. 50, 886\u2013894 (2010). https:\/\/doi.org\/10.1177\/0091270009354996.","journal-title":"J Clin. Pharm."},{"key":"4245_CR23","doi-asserted-by":"publisher","first-page":"110024","DOI":"10.1016\/j.cbi.2022.110024","volume":"363","author":"F Meng","year":"2022","unstructured":"F. Meng, X. Li, J. Li, Y. Zhu, M. Su, B. Zhang et al., Fluornen-9-bisphenol increases Leydig cell proliferation but inhibits maturation in pubertal male rats via interacting with androgen receptor as an antagonist and estrogen receptor \u03b1 as an agonist. Chem Biol. Interact. 363, 110024 (2022). https:\/\/doi.org\/10.1016\/j.cbi.2022.110024.","journal-title":"Chem Biol. Interact."},{"key":"4245_CR24","unstructured":"World Health Orgnization. WHO laboratory manual for the examination and processing of human semen. Availalble from: https:\/\/www.who.int. [Last accessed 27 July 2021]."},{"key":"4245_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"F. Li, W. Si, L. Xia, D. Yin, T. Wei, M. Tao et al., Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer 23, 90 (2024). https:\/\/doi.org\/10.1186\/s12943-024-02008-9.","journal-title":"Mol Cancer"},{"key":"4245_CR26","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1152\/ajpendo.00101.2022","volume":"324","author":"K Wang","year":"2023","unstructured":"K. Wang, X. Cui, F. Li, L. Xia, T. Wei, J. Liu et al., Glucagon receptor blockage inhibits \u03b2-cell dedifferentiation through FoxO1. Am J. Physiol. Endocrinol. Metab. 324, E97\u2013E113 (2023). https:\/\/doi.org\/10.1152\/ajpendo.00101.2022.","journal-title":"Am J. Physiol. Endocrinol. Metab."},{"key":"4245_CR27","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkv1104","volume":"44","author":"C Wu","year":"2016","unstructured":"C. Wu, X. Jin, G. Tsueng, C. Afrasiabi, A.I. Su, BioGPS: building your own mash-up of gene annotations and expression profiles. Nucleic Acids Res 44, D313\u2013D316 (2016). https:\/\/doi.org\/10.1093\/nar\/gkv1104.","journal-title":"Nucleic Acids Res"},{"key":"4245_CR28","doi-asserted-by":"publisher","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","volume":"367","author":"E Sj\u00f6stedt","year":"2020","unstructured":"E. Sj\u00f6stedt, W. Zhong, L. Fagerberg, M. Karlsson, N. Mitsios, C. Adori et al., An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020). https:\/\/doi.org\/10.1126\/science.aay5947.","journal-title":"Science"},{"key":"4245_CR29","doi-asserted-by":"publisher","first-page":"D726","DOI":"10.1093\/nar\/gku967","volume":"43","author":"JT Eppig","year":"2015","unstructured":"J.T. Eppig, J.A. Blake, C.J. Bult, J.A. Kadin, J.E. Richardson, The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res 43, D726\u2013D736 (2015). https:\/\/doi.org\/10.1093\/nar\/gku967.","journal-title":"Nucleic Acids Res"},{"key":"4245_CR30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.fertnstert.2023.10.017","volume":"120","author":"CA Service","year":"2023","unstructured":"C.A. Service, D. Puri, S. Al Azzawi, T.C. Hsieh, D.P. Patel, The impact of obesity and metabolic health on male fertility: a systematic review. Fertil Steril. 120, 1098\u20131111 (2023). https:\/\/doi.org\/10.1016\/j.fertnstert.2023.10.017.","journal-title":"Fertil Steril."},{"key":"4245_CR31","doi-asserted-by":"publisher","unstructured":"G. Salvio, A. Ciarloni, N. Ambo, M. Bordoni, M. Perrone, S. Rossi et al. Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: a systematic review and meta-analysis. Andrology. (2025). https:\/\/doi.org\/10.1111\/andr.70022","DOI":"10.1111\/andr.70022"},{"key":"4245_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.rbmo.2014.07.009","volume":"29","author":"P Fontoura","year":"2014","unstructured":"P. Fontoura, M.C. Cardoso, M.C. Erthal-Martins, C. Werneck, C. Sartorio, C.F. Ramos, The effects of liraglutide on male fertility: a case report. Reprod Biomed. Online 29, 644\u2013646 (2014). https:\/\/doi.org\/10.1016\/j.rbmo.2014.07.009.","journal-title":"Reprod Biomed. Online"},{"key":"4245_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/jcm12020672","volume":"12","author":"S La Vignera","year":"2023","unstructured":"S. La Vignera, R.A. Condorelli, A.E. Calogero, R. Cannarella, A. Aversa, Sexual and reproductive outcomes in obese fertile men with functional hypogonadism after treatment with liraglutide: preliminary results. J Clin. Med 12, 672 (2023). https:\/\/doi.org\/10.3390\/jcm12020672.","journal-title":"J Clin. Med"},{"key":"4245_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5534\/wjmh.2014.32.3.176","volume":"32","author":"A Ahangarpour","year":"2014","unstructured":"A. Ahangarpour, A.A. Oroojan, H. Heidari, Effects of exendin-4 on male reproductive parameters of D-galactose induced aging mouse model. World J. Mens. Health 32, 176\u2013183 (2014). https:\/\/doi.org\/10.5534\/wjmh.2014.32.3.176.","journal-title":"World J. Mens. Health"},{"key":"4245_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/ec-18-0514","volume":"8","author":"M Jensterle","year":"2019","unstructured":"M. Jensterle, A. Podbregar, K. Goricar, N. Gregoric, A. Janez, Effects of liraglutide on obesity-associated functional hypogonadism in men. Endocr Connect 8, 195\u2013202 (2019). https:\/\/doi.org\/10.1530\/ec-18-0514.","journal-title":"Endocr Connect"},{"key":"4245_CR36","doi-asserted-by":"publisher","first-page":"e13039","DOI":"10.1111\/and.13039","volume":"50","author":"N Shao","year":"2018","unstructured":"N. Shao, X.Y. Yu, Y.M. Yu, B.W. Li, J. Pan, W.H. Wu et al., Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. Andrologia 50, e13039 (2018). https:\/\/doi.org\/10.1111\/and.13039.","journal-title":"Andrologia"},{"key":"4245_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1210\/clinem\/dgaa072","volume":"105","author":"C Izzi-Engbeaya","year":"2020","unstructured":"C. Izzi-Engbeaya, S. Jones, Y. Crustna, P.C. Machenahalli, D. Papadopoulou, M. Modi et al., Effects of glucagon-like peptide-1 on the reproductive axis in healthy men. J Clin. Endocrinol. Metab. 105, 1119\u20131125 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa072.","journal-title":"J Clin. Endocrinol. Metab."},{"key":"4245_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120370","volume":"294","author":"ZZ Liu","year":"2022","unstructured":"Z.Z. Liu, X.X. Duan, M.C. Yuan, J. Yu, X. Hu, X. Han et al., Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4\/ROS\/VEGF pathway. Life Sci. 294, 120370 (2022). https:\/\/doi.org\/10.1016\/j.lfs.2022.120370.","journal-title":"Life Sci."},{"key":"4245_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10549-011-1585-0","volume":"132","author":"H Ligumsky","year":"2012","unstructured":"H. Ligumsky, I. Wolf, S. Israeli, M. Haimsohn, S. Ferber, A. Karasik et al., The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Breast Cancer Res Treat. 132, 449\u2013461 (2012). https:\/\/doi.org\/10.1007\/s10549-011-1585-0.","journal-title":"Breast Cancer Res Treat."},{"key":"4245_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1185\/03007995.2015.1103214","volume":"32","author":"XH Guo","year":"2016","unstructured":"X.H. Guo, The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide. Curr Med Res Opin. 32, 61\u201376 (2016). https:\/\/doi.org\/10.1185\/03007995.2015.1103214.","journal-title":"Curr Med Res Opin."},{"key":"4245_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"T. Guo, W. Yan, X. Cui, N. Liu, X. Wei, Y. Sun et al., Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol Med 29, 132 (2023). https:\/\/doi.org\/10.1186\/s10020-023-00721-7.","journal-title":"Mol Med"},{"key":"4245_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115613","volume":"213","author":"S Mahalingam","year":"2023","unstructured":"S. Mahalingam, R. Bellamkonda, M.K. Arumugam, S.K. Perumal, J. Yoon, C. Casey et al., Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease. Biochem Pharm. 213, 115613 (2023). https:\/\/doi.org\/10.1016\/j.bcp.2023.115613.","journal-title":"Biochem Pharm."},{"key":"4245_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"D.J. Drucker, Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27, 740\u2013756 (2018).","journal-title":"Cell Metab"},{"key":"4245_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/humupd\/dmz019","volume":"25","author":"M Jensterle","year":"2019","unstructured":"M. Jensterle, A. Janez, E. Fliers, J.H. DeVries, E. Vrtacnik-Bokal, S.E. Siegelaar, The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective. Hum Reprod. Update 25, 504\u2013517 (2019). https:\/\/doi.org\/10.1093\/humupd\/dmz019.","journal-title":"Hum Reprod. Update"},{"key":"4245_CR45","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"D.J. Drucker, J.J. Holst, The expanding incretin universe: from basic biology to clinical translation. Diabetologia 66, 1765\u20131779 (2023). https:\/\/doi.org\/10.1007\/s00125-023-05906-7.","journal-title":"Diabetologia"},{"key":"4245_CR46","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa031","volume":"161","author":"V Rago","year":"2020","unstructured":"V. Rago, D. De Rose, M. Santoro, S. Panza, R. Malivindi, S. And\u00f2 et al., Human sperm express the receptor for glucagon-like peptide-1 (GLP-1), which affects sperm function and metabolism. Endocrinology 161, bqaa031 (2020). https:\/\/doi.org\/10.1210\/endocr\/bqaa031.","journal-title":"Endocrinology"},{"key":"4245_CR47","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/andr.12871","volume":"8","author":"R Caltabiano","year":"2020","unstructured":"R. Caltabiano, D. Condorelli, S. Panza, C. Boitani, N. Musso, D. Je\u017eek et al., Glucagon-like peptide-1 receptor is expressed in human and rodent testis. Andrology 8, 1935\u20131945 (2020). https:\/\/doi.org\/10.1111\/andr.12871.","journal-title":"Andrology"},{"key":"4245_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/medicina60010050","volume":"60","author":"AA Varnum","year":"2023","unstructured":"A.A. Varnum, E. Pozzi, N.A. Deebel, A. Evans, N. Eid, H. Sadeghi-Nejad et al., Impact of GLP-1 agonists on male reproductive health-a narrative review. Medicina (Kaunas.) 60, 50 (2023). https:\/\/doi.org\/10.3390\/medicina60010050.","journal-title":"Medicina (Kaunas.)"},{"key":"4245_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.10.009","volume":"362","author":"AD Martins","year":"2019","unstructured":"A.D. Martins, M.P. Monteiro, B.M. Silva, A. Barros, M. Sousa, R.A. Carvalho et al., Metabolic dynamics of human sertoli cells are differentially modulated by physiological and pharmacological concentrations of GLP-1. Toxicol Appl Pharm. 362, 1\u20138 (2019). https:\/\/doi.org\/10.1016\/j.taap.2018.10.009.","journal-title":"Toxicol Appl Pharm."},{"key":"4245_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1292\/jvms.24-0042","volume":"86","author":"M Iida","year":"2024","unstructured":"M. Iida, A. Asano, Effects of glucagon-like peptide-1 receptor agonists on spermatogenesis-related gene expression in mouse testis and testis-derived cell lines. J Vet. Med Sci. 86, 555\u2013562 (2024). https:\/\/doi.org\/10.1292\/jvms.24-0042.","journal-title":"J Vet. Med Sci."},{"key":"4245_CR51","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1210\/endo.141.2.7326","volume":"141","author":"NJ MacLusky","year":"2000","unstructured":"N.J. MacLusky, S. Cook, L. Scrocchi, J. Shin, J. Kim, F. Vaccarino, S.L. Asa, D.J. Drucker, Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology 141, 752\u2013762 (2000). https:\/\/doi.org\/10.1210\/endo.141.2.7326.","journal-title":"Endocrinology"},{"key":"4245_CR52","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/biom12121736","volume":"12","author":"D Khan","year":"2022","unstructured":"D. Khan, O.O. Ojo, O.R. Woodward, J.E. Lewis, A. Sridhar, F.M. Gribble et al., Evidence for involvement of GIP and GLP-1 receptors and the gut-gonadal axis in regulating female reproductive function in mice. Biomolecules 12, 1736 (2022). https:\/\/doi.org\/10.3390\/biom12121736.","journal-title":"Biomolecules"},{"key":"4245_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.838858","volume":"13","author":"JM Wang","year":"2022","unstructured":"J.M. Wang, Z.F. Li, W.X. Yang, What does androgen receptor signaling pathway in sertoli cells during normal spermatogenesis tell us?. Front Endocrinol. (Lausanne) 13, 838858 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.838858.","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"4245_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tem.2016.12.004","volume":"28","author":"PF Oliveira","year":"2017","unstructured":"P.F. Oliveira, C.Y. Cheng, M.G. Alves, Emerging role for mammalian target of rapamycin in male fertility. Trends Endocrinol. Metab. 28, 165\u2013167 (2017). https:\/\/doi.org\/10.1016\/j.tem.2016.12.004.","journal-title":"Trends Endocrinol. Metab."},{"key":"4245_CR55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.molmed.2023.06.010","volume":"29","author":"H Arora","year":"2023","unstructured":"H. Arora, Leptin and male fertility: Unraveling the molecular pathways, receptor functions, and therapeutic potential. Trends Mol. Med 29, 880\u2013882 (2023). https:\/\/doi.org\/10.1016\/j.molmed.2023.06.010.","journal-title":"Trends Mol. Med"},{"key":"4245_CR56","doi-asserted-by":"publisher","first-page":"1274035","DOI":"10.3389\/fendo.2023.1274035","volume":"14","author":"S Falvo","year":"2023","unstructured":"S. Falvo, S. Minucci, A. Santillo, R. Senese, G. Chieffi Baccari, M. Venditti, A short-term high-fat diet alters rat testicular activity and blood-testis barrier integrity through the SIRT1\/NRF2\/MAPKs signaling pathways. Front Endocrinol. (Lausanne) 14, 1274035 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1274035.","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"4245_CR57","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1172\/jci99934","volume":"130","author":"MA Siraj","year":"2020","unstructured":"M.A. Siraj, D. Mundil, S. Beca, A. Momen, E.A. Shikatani, T. Afroze et al., Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-\u03b1. J Clin. Invest 130, 1392\u20131404 (2020). https:\/\/doi.org\/10.1172\/jci99934.","journal-title":"J Clin. Invest"},{"key":"4245_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00583-2","volume":"18","author":"RM Pelletier","year":"2020","unstructured":"R.M. Pelletier, H. Layeghkhavidaki, M.L. Vitale, Glucose, insulin, insulin receptor subunits \u03b1 and \u03b2 in normal and spontaneously diabetic and obese ob\/ob and db\/db infertile mouse testis and hypophysis. Reprod Biol. Endocrinol. 18, 25 (2020). https:\/\/doi.org\/10.1186\/s12958-020-00583-2.","journal-title":"Reprod Biol. Endocrinol."},{"key":"4245_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ng0396-318","volume":"12","author":"FF Chehab","year":"1996","unstructured":"F.F. Chehab, M.E. Lim, R. Lu, Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12, 318\u2013320 (1996). https:\/\/doi.org\/10.1038\/ng0396-318.","journal-title":"Nat Genet"},{"key":"4245_CR60","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1177\/0091270010389468","volume":"51","author":"J Jiang","year":"2011","unstructured":"J. Jiang, J. Zhang, L.V. Jacobsen, P. Hu, The pharmacokinetics, pharmacodynamics, and tolerability of liraglutide, a once-daily human GLP-1 analogue, after multiple subcutaneous administration in healthy Chinese male subjects. J Clin. Pharm. 51, 1620\u20131627 (2011). https:\/\/doi.org\/10.1177\/0091270010389468.","journal-title":"J Clin. Pharm."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04245-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04245-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04245-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:22:28Z","timestamp":1757172148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04245-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4245"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04245-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of Peking University (Approval No. PUIRB-LA2023522).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}